Clinical and laboratory remission with rituximab in anti-MuSK-positive myasthenia gravis.

Berin Inan Irem Gul Orhan Can Ebru Bekircan-Kurt Sevim Erdem Özdamar Ersin Tan

Published in: Irish journal of medical science (2024)

RTX is an effective treatment in anti-MuSK-positive MG. Furthermore, our results support the inhibition of antibody production by RTX and we recommend monitoring anti-MuSK antibody titers to follow disease progression and treatment response.

Keyphrases

myasthenia gravis
diffuse large b cell lymphoma
rheumatoid arthritis
hodgkin lymphoma